Tag: life-sciences
AbCellera Biologics Stock Analysis: Buy or Sell? Valuation & Cash Burn
AbCellera Biologics Inc. (ABCL) is rated STRONG SELL as valuation still assumes a much faster clinical and commercial ramp than current results support. Despite a large cash balance, ongoing cash burn and rich revenue multiples leave little margin of safety.
Schrödinger Stock Analysis: Buy or Sell? Valuation & Cash Burn
Schrödinger (SDGR) is rated Sell because its platform quality has not yet translated into durable cash generation. The valuation still assumes stronger growth, while operating cash flow remains deeply negative and free cash flow is not consistently positive.